T80.419S
✓ BillableRh incompatibility with hemolytic transfusion reaction, unspecified, sequela
Injury, poisoning and certain other consequences of external causes (S00-T88)
⚠️ Excludes2
inheritedRules inherited from parent codes.
- • bone marrow transplant rejection (T86.01)
- • febrile nonhemolytic transfusion reaction (R50.84)
- • fluid overload due to transfusion (E87.71)
- • posttransfusion purpura (D69.51)
- • transfusion associated circulatory overload (TACO) (E87.71)
- • transfusion (red blood cell) associated hemochromatosis (E83.111)
- • transfusion related acute lung injury (TRALI) (J95.84)
Clinical Description
ICD-10-CM code T80.419S represents rh incompatibility with hemolytic transfusion reaction, unspecified, sequela. This code falls under the Injury, poisoning and certain other consequences of external causes (S00-T88) classification. It is a billable/specific code valid for HIPAA-covered transactions as of October 1, 2025 (FY2026). This code can be used to indicate a diagnosis for reimbursement purposes on insurance claims.
This is a 8-character code at the 7th level of specificity. This is the most specific code available in this subcategory.
Frequently Asked Questions
What is ICD-10 code T80.419S?
ICD-10-CM code T80.419S is "Rh incompatibility with hemolytic transfusion reaction, unspecified, sequela". It belongs to the category: Injury, poisoning and certain other consequences of external causes (S00-T88).
Is T80.419S a billable ICD-10 code?
Yes, T80.419S is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
Can T80.419S be coded with other codes?
T80.419S has 7 Excludes2 note(s). These conditions can be coded together if both are documented in the patient record.
Related Codes in T80.419
Other codes in the same category that may be relevant for differential coding:
🧪 Validate Combinations
Add T80.419S to the Excludes Checker to validate against your full code list.
Open in Checker →Code Information
Data Source
CMS ICD-10-CM 2026 Tabular List
Updated October 1, 2025 (FY2026)